This study provides the first comprehensive analysis of the PPM1B/MP/PRMT5/histone signaling pathway in human lung cancer tissues, revealing a novel oncogenic mechanism that distinguishes between ADC and SCC subtypes. Here, PPM1B is linked to lung cancer.